Association Between Hormones and Metabolic Syndrome in Older Italian Men
- 7 December 2006
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 54 (12) , 1832-1838
- https://doi.org/10.1111/j.1532-5415.2006.00963.x
Abstract
OBJECTIVES: To determine whether low levels of testosterone, sex hormone binding globulin (SHBG), insulin‐like growth factor‐1 (IGF‐1), and dehydroepiandrosterone sulfate (DHEAS) and high levels of cortisol and leptin would be associated with metabolic syndrome (MS). DESIGN: Cross‐sectional. SETTING: Population‐based sample of older Italian men. PARTICIPANTS: Four hundred fifty‐two men aged 65 and older enrolled in the Invecchiare in Chianti (InCHIANTI) study. MEASUREMENTS: Complete data on testosterone, cortisol, DHEAS, SHBG, fasting insulin, IGF‐1 and leptin. MS was defined according to Adult Treatment Panel III criteria. RESULTS: MS was present in 73 men (15.8% of the sample). After adjusting for confounders, total testosterone (P<.05) and log (SHBG) (P<.001) were inversely associated, whereas log (leptin) was positively associated with MS (P<.001). Independent of age, log (SHBG) was positively associated with high‐density lipoprotein cholesterol (P<.05) and negatively associated with abdominal obesity (P<.001) and triglycerides (P<.001). Log (leptin) was significantly associated with each component of MS. Cortisol, DHEAS, free and bioavailable testosterone, and IGF‐1 were not associated with MS. Having three or more hormones in the lower (for hormones lower in MS) or the upper (for hormones higher in MS) quartile was associated with three times the risk of being affected by MS (odds ratio=2.8, 95% confidence interval=1.3–6.9) (P=.005), compared with not having this condition. CONCLUSION: Total testosterone and SHBG are negatively and leptin is positively associated with MS in older men. Whether specific patterns of hormonal dysregulation predict the development of MS should be tested in longitudinal studies.Keywords
This publication has 39 references indexed in Scilit:
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapyCancer, 2005
- Cardiovascular Issues in Hypogonadism and Testosterone TherapyThe American Journal of Cardiology, 2005
- Definition of Metabolic SyndromeCirculation, 2004
- Leptin: a review of its peripheral actions and interactionsInternational Journal of Obesity, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The metabolic syndrome — a neuroendocrine disorder?British Journal of Nutrition, 2000
- Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centresInternational Journal of Epidemiology, 1997
- Acute and chronic regulation of serum sex hormone-binding globulin levels by plasma insulin concentrations in male noninsulin-dependent diabetes mellitus patientsJournal of Clinical Endocrinology & Metabolism, 1996
- Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular riskThe Journal of Steroid Biochemistry and Molecular Biology, 1995